Hsi‐Ming Lee

2.3k total citations
44 papers, 1.8k citations indexed

About

Hsi‐Ming Lee is a scholar working on Periodontics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hsi‐Ming Lee has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Periodontics, 11 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hsi‐Ming Lee's work include Oral microbiology and periodontitis research (20 papers), Protease and Inhibitor Mechanisms (10 papers) and Curcumin's Biomedical Applications (7 papers). Hsi‐Ming Lee is often cited by papers focused on Oral microbiology and periodontitis research (20 papers), Protease and Inhibitor Mechanisms (10 papers) and Curcumin's Biomedical Applications (7 papers). Hsi‐Ming Lee collaborates with scholars based in United States, Finland and China. Hsi‐Ming Lee's co-authors include Lorne M. Golub, Timo Sorsa, Gary F. Nieman, Jay Steinberg, Jeffrey M. Halter, Louis A. Gatto, Henry J. Schiller, Francis Johnson, Yrjö T. Konttinen and Babak Vakili and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Hsi‐Ming Lee

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsi‐Ming Lee United States 23 649 350 296 262 221 44 1.8k
César Rivera Chile 18 428 0.7× 246 0.7× 651 2.2× 356 1.4× 104 0.5× 66 1.7k
Maria Ryan United States 27 1.4k 2.2× 145 0.4× 413 1.4× 536 2.0× 157 0.7× 60 3.0k
Hao Chen China 23 339 0.5× 283 0.8× 751 2.5× 341 1.3× 395 1.8× 126 2.0k
Hong Hua China 26 474 0.7× 184 0.5× 508 1.7× 133 0.5× 311 1.4× 116 2.1k
Chuan‐Hang Yu Taiwan 28 577 0.9× 314 0.9× 613 2.1× 435 1.7× 76 0.3× 89 1.8k
Diana V. Messadi United States 28 531 0.8× 204 0.6× 510 1.7× 260 1.0× 61 0.3× 55 2.0k
Nicola Cirillo Australia 34 930 1.4× 356 1.0× 923 3.1× 461 1.8× 348 1.6× 163 3.6k
Marco Mascitti Italy 24 273 0.4× 196 0.6× 384 1.3× 152 0.6× 88 0.4× 77 1.3k
Jack W. Martin United States 16 429 0.7× 330 0.9× 380 1.3× 135 0.5× 38 0.2× 38 1.6k
Alessandro Polizzi Italy 24 1.1k 1.6× 100 0.3× 382 1.3× 108 0.4× 84 0.4× 93 1.9k

Countries citing papers authored by Hsi‐Ming Lee

Since Specialization
Citations

This map shows the geographic impact of Hsi‐Ming Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsi‐Ming Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsi‐Ming Lee more than expected).

Fields of papers citing papers by Hsi‐Ming Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsi‐Ming Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsi‐Ming Lee. The network helps show where Hsi‐Ming Lee may publish in the future.

Co-authorship network of co-authors of Hsi‐Ming Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Hsi‐Ming Lee. A scholar is included among the top collaborators of Hsi‐Ming Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsi‐Ming Lee. Hsi‐Ming Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Ying, et al.. (2025). Diabetes, periodontal disease, and novel therapeutic approaches- host modulation therapy. Frontiers in Clinical Diabetes and Healthcare. 6. 1529086–1529086. 1 indexed citations
2.
Golub, Lorne M., Hsi‐Ming Lee, Thomas Zimmerman, et al.. (2023). Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss. Journal of Inflammation Research. Volume 16. 779–792. 3 indexed citations
3.
Deng, Jie, Lorne M. Golub, Hsi‐Ming Lee, et al.. (2023). A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization. Scientific Reports. 13(1). 15513–15513. 7 indexed citations
4.
Golub, Lorne M., et al.. (2021). A Novel Concept to Promote the Health of Dental Implants: Host-Modulation Therapy. International Journal of Physical Medicine & Rehabilitation. 1–2.
6.
Curylofo‐Zotti, Fabiana Almeida, Muna S. Elburki, Paulo Sérgio Cerri, et al.. (2018). Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis. Archives of Oral Biology. 91. 42–50. 47 indexed citations
8.
Zhang, Yu, et al.. (2012). Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins. Current Medicinal Chemistry. 19(25). 4348–4358. 58 indexed citations
9.
Payne, Jeffrey B., Lorne M. Golub, Julie A. Stoner, et al.. (2011). The effect of subantimicrobial-dose–doxycycline periodontal therapy on serum biomarkers of systemic inflammation. The Journal of the American Dental Association. 142(3). 262–273. 68 indexed citations
10.
Chang, Shih‐Chia, et al.. (2010). SOCIAL CAPITAL, CREATIVITY, AND NEW PRODUCT ADVANTAGE: AN EMPIRICAL STUDY. Int. J. Electron. Bus. Manag.. 8. 43–55. 23 indexed citations
11.
Payne, Jeffrey B., et al.. (2007). Inflammatory mediator release following bone grafting in humans: a pilot study. Journal Of Clinical Periodontology. 34(9). 797–804. 3 indexed citations
12.
Halter, Jeffrey M., Jay Steinberg, Louis A. Gatto, et al.. (2007). Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability. Critical Care. 11(1). R20–R20. 91 indexed citations
13.
Payne, Jeffrey B., Julie A. Stoner, Pirkka V. Nummikoski, et al.. (2007). Subantimicrobial dose doxycycline effects on alveolar bone loss in post‐menopausal women. Journal Of Clinical Periodontology. 34(9). 776–787. 37 indexed citations
14.
Halter, Jeffrey M., Jay Steinberg, Charles J. Lutz, et al.. (2005). Evidence of Systemic Cytokine Release in Patients Undergoing Cardiopulmonary Bypass. Journal of ExtraCorporeal Technology. 37(3). 272–277. 55 indexed citations
15.
Gu, Ying, Hsi‐Ming Lee, Lorne M. Golub, et al.. (2005). Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Annals of Medicine. 37(6). 450–460. 18 indexed citations
16.
Steinberg, Jay, Jeffrey M. Halter, Henry J. Schiller, et al.. (2005). CHEMICALLY MODIFIED TETRACYCLINE PREVENTS THE DEVELOPMENT OF SEPTIC SHOCK AND ACUTE RESPIRATORY DISTRESS SYNDROME IN A CLINICALLY APPLICABLE PORCINE MODEL. Shock. 24(4). 348–356. 75 indexed citations
17.
Steinberg, Jay, Henry J. Schiller, Jeffrey M. Halter, et al.. (2003). Alveolar Instability Causes Early Ventilator-induced Lung Injury Independent of Neutrophils. American Journal of Respiratory and Critical Care Medicine. 169(1). 57–63. 112 indexed citations
18.
Steinberg, Jay, Jeffrey M. Halter, Henry J. Schiller, et al.. (2003). Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. Journal of Surgical Research. 111(2). 185–195. 149 indexed citations
19.
Steinberg, Jay, G Fink, Anthony Picone, et al.. (2001). Evidence of Increased Matrix Metalloproteinase-9 Concentration in Patients Following Cardiopulmonary Bypass. Journal of ExtraCorporeal Technology. 33(4). 218–222. 20 indexed citations
20.
Vernillo, Anthony, N.S. Ramamurthy, Hsi‐Ming Lee, & Barry R. Rifkin. (1990). The Effect of Phenytoin on Collagenase and Gelatinase Activities in UMR 106-01 Rat Osteoblastic Osteosarcoma Cells. Matrix. 10(1). 27–32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026